New Approaches to Radiation Protection

Frontiers in Oncology

Volumn 4, Issue , 2015, Pages

  Rosen, Eliot M ^a   Day, Regina ^b   Singh, Vijay K ^b,c  

^a GEORGETOWN UNIVERSITY   (United States)

^b Uniformed Services University of the Health Sciences   (United States)

^c ARMED FORCES RADIOBIOLOGY RESEARCH INSTITUTE   (United States)

Author keywords

cancer treatment; irradiation; mitigators; radiation protection; radioprotectors

Indexed keywords

EID: 84962971719     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2014.00381     Document Type: Review

References (202)

1. Anno GH Baum SJ Withers HR Young RW. Symptomatology of acute radiation effects in humans after exposure to doses of 0.5-30 Gy. Health Phys (1989) 56(6):821–38.10.1097/00004032-198906000-000012722506
2. Dainiak N. Hematologic consequences of exposure to ionizing radiation. Exp Hematol (2002) 30(6):513–28.10.1016/S0301-472X(02)00802-012063018
3. Waselenko JK MacVittie TJ Blakely WF Pesik N Wiley AL Dickerson WE et al. Medical management of the acute radiation syndrome: recommendations of the Strategic National Stockpile Radiation Working Group. Ann Intern Med (2004) 140(12):1037–51.10.7326/0003-4819-140-12-200406150-00015
4. Williams JP Brown SL Georges GE Hauer-Jensen M Hill RP Huser AK et al. Animal models for medical countermeasures to radiation exposure. Radiat Res (2010) 173(4):557–78.10.1667/RR1880.120334528
5. Drouet M Herodin F. Radiation victim management and the haematologist in the future: time to revisit therapeutic guidelines? Int J Radiat Biol (2010) 86(8):636–48.10.3109/0955300100378960420597842
6. Booth C Tudor G Tudor J Katz BP MacVittie TJ. Acute gastrointestinal syndrome in high-dose irradiated mice. Health Phys (2012) 103(4):383–99.10.1097/HP.0b013e318266ee1323091876
7. Hosseinimehr SJ. Trends in the development of radioprotective agents. Drug Discov Today (2007) 12(19–20):794–805.10.1016/j.drudis.2007.07.017
8. Na Nakorn T Traver D Weissman IL Akashi K. Myeloerythroid-restricted progenitors are sufficient to confer radioprotection and provide the majority of day 8 CFU-S. J Clin Invest (2002) 109(12):1579–85.10.1172/JCI20021527212070305
9. Meijne EI van der Winden-van Groenewegen RJ Ploemacher RE Vos O David JA Huiskamp R. The effects of x-irradiation on hematopoietic stem cell compartments in the mouse. Exp Hematol (1991) 19(7):617–23.1893947
10. Takahashi K Monzen S Hayashi N Kashiwakura I. Correlations of cell surface antigens with individual differences in radiosensitivity in human hematopoietic stem/progenitor cells. Radiat Res (2010) 173(2):184–90.10.1667/RR1839.120095850
11. Qiu W Carson-Walter EB Liu H Epperly M Greenberger JS Zambetti GP et al. PUMA regulates intestinal progenitor cell radiosensitivity and gastrointestinal syndrome. Cell Stem Cell (2008) 2(6):576–83.10.1016/j.stem.2008.03.00918522850
12. Qiu W Leibowitz B Zhang L Yu J. Growth factors protect intestinal stem cells from radiation-induced apoptosis by suppressing PUMA through the PI3K/AKT/p53 axis. Oncogene (2010) 29(11):1622–32.10.1038/onc.2009.45119966853
13. Singh PK Wise SY Ducey EJ Fatanmi OO Elliott TB Singh VK. Alpha-tocopherol succinate protects mice against radiation-induced gastrointestinal injury. Radiat Res (2012) 177(2):133–45.10.1667/RR2627.122013885
14. Calveley VL Khan MA Yeung IW Vandyk J Hill RP. Partial volume rat lung irradiation: temporal fluctuations of in-field and out-of-field DNA damage and inflammatory cytokines following irradiation. Int J Radiat Biol (2005) 81(12):887–99.10.1080/0955300060056800216524844
15. Augustine AD Gondre-Lewis T McBride W Miller L Pellmar TC Rockwell S. Animal models for radiation injury, protection and therapy. Radiat Res (2005) 164(1):100–9.10.1667/RR338815966769
16. Down JD. The nature and relevance of late lung pathology following localised irradiation of the thorax in mice and rats. Br J Cancer Suppl (1986) 7:330–2.
17. Day RM Barshishat-Kupper M Mog SR McCart EA Prasanna PG Davis TA et al. Genistein protects against biomarkers of delayed lung sequelae in mice surviving high-dose total body irradiation. J Radiat Res (2008) 49(4):361–72.10.1269/jrr.0712118434686
18. Bloomer WD Hellman S. Normal tissue responses to radiation therapy. N Engl J Med (1975) 293(2):80–3.10.1056/NEJM197507102930206
19. Hellman S. Cell kinetics, models, and cancer treatment – some principles for the radiation oncologist. Radiology (1975) 114(1):219–23.10.1148/114.1.2191208863
20. Monson JM Stark P Reilly JJ Sugarbaker DJ Strauss GM Swanson SJ et al. Clinical radiation pneumonitis and radiographic changes after thoracic radiation therapy for lung carcinoma. Cancer (1998) 82(5):842–50.10.1002/(SICI)1097-0142(19980301)82:5<842::AID-CNCR7>3.3.CO;2-O9486572
21. Johansson S Bjermer L Franzen L Henriksson R. Effects of ongoing smoking on the development of radiation-induced pneumonitis in breast cancer and oesophagus cancer patients. Radiother Oncol (1998) 49(1):41–7.10.1016/S0167-8140(98)00064-49886696
22. Bradley J Movsas B. Radiation pneumonitis and oesophagitis in thoracic irradiation. In: Small W Woloschak GE, editors. Radiation Toxicity: A Practical Guide. New York, NY: Springer Science and Media Business, Inc. (2006). p. 43–52.
23. Bentzen SM. Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology. Nat Rev Cancer (2006) 6(9):702–13.10.1038/nrc195016929324
24. Hopewell JW Millar WT Ang KK. Toward improving the therapeutic ratio in stereotactic radiosurgery: selective modulation of the radiation responses of both normal tissues and tumor. J Neurosurg (2007) 107(1):84–93.10.3171/JNS-07/07/008417639878
25. Berkey FJ. Managing the adverse effects of radiation therapy. Am Fam Physician (2010) 82(4):381–8, 394.20704169
26. Petersen C Wurschmidt F. Late toxicity of radiotherapy: a problem or a challenge for the radiation oncologist? Breast Care (Basel) (2011) 6(5):369–74.10.1159/00033422022619647
27. Werner-Wasik M Pequignot E Leeper D Hauck W Curran W. Predictors of severe esophagitis include use of concurrent chemotherapy, but not the length of irradiated esophagus: a multivariate analysis of patients with lung cancer treated with nonoperative therapy. Int J Radiat Oncol Biol Phys (2000) 48(3):689–96.10.1016/S0360-3016(00)00699-411020565
28. Nguyen NP Sallah S Karlsson U Antoine JE. Combined chemotherapy and radiation therapy for head and neck malignancies: quality of life issues. Cancer (2002) 94(4):1131–41.10.1002/cncr.1025711920484
29. Lee JH Paull TT. Activation and regulation of ATM kinase activity in response to DNA double-strand breaks. Oncogene (2007) 26(56):7741–8.10.1038/sj.onc.121087218066086
30. Guida C Maione P Rossi A Bareschino M Schettino C Barzaghi D et al. Combined chemo-radiotherapy for locally advanced non-small cell lung cancer: current status and future development. Crit Rev Oncol Hematol (2008) 68(3):222–32.10.1016/j.critrevonc.2008.05.00718632283
31. Marur S Forastiere AA. Challenges of integrating chemotherapy and targeted therapy with radiation in locally advanced head and neck squamous cell cancer. Curr Opin Oncol (2010) 22(3):206–11.10.1097/CCO.0b013e328338475c20216313
32. Ring KL Young JL Dunlap NE Andersen WA Schneider BF. Extended-field radiation therapy with whole pelvis radiotherapy and cisplatin chemosensitization in the treatment of IB2-IIIB cervical carcinoma: a retrospective review. Am J Obstet Gynecol (2009) 201(1):109.e1–6.10.1016/j.ajog.2009.03.022
33. Merchant TE Pollack IF Loeffler JS. Brain tumors across the age spectrum: biology, therapy, and late effects. Semin Radiat Oncol (2010) 20(1):58–66.10.1016/j.semradonc.2009.09.00519959032
34. Duffner PK. Risk factors for cognitive decline in children treated for brain tumors. Eur J Paediatr Neurol (2010) 14:106–15.10.1016/j.ejpn.2009.10.00519931477
35. Boerma M Hauer-Jensen M. Potential targets for intervention in radiation-induced heart disease. Curr Drug Targets (2010) 11(11):1405–12.10.2174/138945011100901140520583977
36. Andratschke N Maurer J Molls M Trott KR. Late radiation-induced heart disease after radiotherapy. Clinical importance, radiobiological mechanisms and strategies of prevention. Radiother Oncol (2011) 100(2):160–6.10.1016/j.radonc.2010.08.01020826032
37. Campen CJ Kranick SM Kasner SE Kessler SK Zimmerman RA Lustig R et al. Cranial irradiation increases risk of stroke in pediatric brain tumor survivors. Stroke (2012) 43(11):3035–40.10.1161/STROKEAHA.112.66156122968468
38. Adams GE Jameson DG. Time effects in molecular radiation biology. Radiat Environ Biophys (1980) 17(2):95–113.10.1007/BF02027847
39. Tallentire A. Oxygen effect, hydrogen peroxide yields, and time scale of interaction of potentially damaging species in electron pulse irradiated bacterial spores. Adv Space Res (1983) 3(8):105–12.10.1016/0273-1177(83)90180-111542738
40. Wardman P Ross AB. “Radiation chemistry” literature compilations: their wider value in free radical research. Free Radic Biol Med (1991) 10(3–4):243–7.10.1016/0891-5849(91)90081-D1650739
41. Gutteridge JM Halliwell B. Free radicals and antioxidants in the year 2000. A historical look to the future. Ann N Y Acad Sci (2000) 899:136–47.10.1111/j.1749-6632.2000.tb06182.x10863535
42. Revesz L Palcic B. Radiation dose dependence of the sensitization by oxygen and oxygen mimic sensitizers. Acta Radiol Oncol (1985) 24(3):209–17.10.3109/028418685091343892994369
43. Guichard M. Hypoxia as a determinant factor in radiotherapy? Where are we? BJR Suppl (1992) 24:142–5.
44. Yoshimura M Itasaka S Harada H Hiraoka M. Microenvironment and radiation therapy. Biomed Res Int (2013) 2013:685308.10.1155/2013/68530823509762
45. Skov KA. The contribution of hydroxyl radical to radiosensitization: a study of DNA damage. Radiat Res (1984) 99(3):502–10.10.2307/35763266089257
46. Roots R Chatterjee A Chang P Lommel L Blakely EA. Characterization of hydroxyl radical-induced damage after sparsely and densely ionizing irradiation. Int J Radiat Biol Relat Stud Phys Chem Med (1985) 47(2):157–66.10.1080/095530085145502312984128
47. Corre I Niaudet C Paris F. Plasma membrane signaling induced by ionizing radiation. Mutat Res (2010) 704(1–3):61–7.10.1016/j.mrrev.2010.01.01420117234
48. Chatgilialoglu C Ferreri C Torreggiani A Salzano AM Renzone G Scaloni A. Radiation-induced reductive modifications of sulfur-containing amino acids within peptides and proteins. J Proteomics (2011) 74(11):2264–73.10.1016/j.jprot.2011.03.01221447412
49. Breen AP Murphy JA. Reactions of oxyl radicals with DNA. Free Radic Biol Med (1995) 18(6):1033–77.10.1016/0891-5849(94)00209-37628729
50. Epe B. DNA damage profiles induced by oxidizing agents. Rev Physiol Biochem Pharmacol (1996) 127:223–49.10.1007/BFb0048268
51. Wallace SS. Enzymatic processing of radiation-induced free radical damage in DNA. Radiat Res (1998) 150(5 Suppl):S60–79.10.2307/35798099806610
52. Slupphaug G Kavli B Krokan HE. The interacting pathways for prevention and repair of oxidative DNA damage. Mutat Res (2003) 531(1–2):231–51.10.1016/j.mrfmmm.2003.06.00214637258
53. Lee JH Paull TT. ATM activation by DNA double-strand breaks through the Mre11-Rad50-Nbs1 complex. Science (2005) 308(5721):551–4.10.1126/science.110829715790808
54. Lavin MF Kozlov S. ATM activation and DNA damage response. Cell Cycle (2007) 6(8):931–42.10.4161/cc.6.8.418017457059
55. Moynahan ME Jasin M. Mitotic homologous recombination maintains genomic stability and suppresses tumorigenesis. Nat Rev Mol Cell Biol (2010) 11(3):196–207.10.1038/nrm285120177395
56. Lieber MR. The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway. Annu Rev Biochem (2010) 79:181–211.10.1146/annurev.biochem.052308.09313120192759
57. Stracker TH Roig I Knobel PA Marjanovic M. The ATM signaling network in development and disease. Front Genet (2013) 4:37.10.3389/fgene.2013.0003723532176
58. Huang TT Wuerzberger-Davis SM Wu ZH Miyamoto S. Sequential modification of NEMO/IKKgamma by SUMO-1 and ubiquitin mediates NF-kappaB activation by genotoxic stress. Cell (2003) 115(5):565–76.10.1016/S0092-8674(03)00895-X14651848
59. Sakamoto K Hikiba Y Nakagawa H Hirata Y Hayakawa Y Kinoshita H et al. Promotion of DNA repair by nuclear IKKbeta phosphorylation of ATM in response to genotoxic stimuli. Oncogene (2013) 32(14):1854–62.10.1038/onc.2012.19222614018
60. Little MP Heidenreich WF Moolgavkar SH Schollnberger H Thomas DC. Systems biological and mechanistic modelling of radiation-induced cancer. Radiat Environ Biophys (2008) 47(1):39–47.10.1007/s00411-007-0150-z18097677
61. Newhauser WD Durante M. Assessing the risk of second malignancies after modern radiotherapy. Nat Rev Cancer (2011) 11(6):438–48.10.1038/nrc306921593785
62. Williams JP McBride WH. After the bomb drops: a new look at radiation-induced multiple organ dysfunction syndrome (MODS). Int J Radiat Biol (2011) 87(8):851–68.10.3109/09553002.2011.56099621417595
63. Hong JH Chiang CS Tsao CY Lin PY Wu CJ McBride WH. Can short-term administration of dexamethasone abrogate radiation-induced acute cytokine gene response in lung and modify subsequent molecular responses? Int J Radiat Oncol Biol Phys (2001) 51(2):296–303.10.1016/S0360-3016(01)01702-311567802
64. Hong JH Jung SM Tsao TC Wu CJ Lee CY Chen FH et al. Bronchoalveolar lavage and interstitial cells have different roles in radiation-induced lung injury. Int J Radiat Biol (2003) 79(3):159–67.10.1080/095530003100007689412745880
65. Yarnold J Brotons MC. Pathogenetic mechanisms in radiation fibrosis. Radiother Oncol (2010) 97(1):149–61.10.1016/j.radonc.2010.09.002
66. Kouvaris JR Kouloulias VE Vlahos LJ. Amifostine: the first selective-target and broad-spectrum radioprotector. Oncologist (2007) 12(6):738–47.10.1634/theoncologist.12-6-73817602063
67. Schuchter LM. Exploration of platinum-based dose-intensive chemotherapy strategies with amifostine (Ethyol). Eur J Cancer (1996) 32A(Suppl 4):S40–2.10.1016/S0959-8049(96)00316-48976821
68. Ali BH Al Moundhri MS. Agents ameliorating or augmenting the nephrotoxicity of cisplatin and other platinum compounds: a review of some recent research. Food Chem Toxicol (2006) 44(8):1173–83.10.1016/j.fct.2006.01.01316530908
69. Chirino YI Pedraza-Chaverri J. Role of oxidative and nitrosative stress in cisplatin-induced nephrotoxicity. Exp Toxicol Pathol (2009) 61(3):223–42.10.1016/j.etp.2008.09.00318986801
70. van der Vijgh WJ Peters GJ. Protection of normal tissues from the cytotoxic effects of chemotherapy and radiation by amifostine (Ethyol): preclinical aspects. Semin Oncol (1994) 21(5 Suppl 11):2–7.
71. Bourhis J Rosine D. Radioprotective effect of amifostine in patients with head and neck squamous cell carcinoma. Semin Oncol (2002) 29(6 Suppl 19):61–2.10.1053/sonc.2002.3734912577247
72. Karacetin D Yucel B Leblebicioglu B Aksakal O Maral O Incekara O. A randomized trial of amifostine as radioprotector in the radiotherapy of head and neck cancer. J BUON (2004) 9(1):23–6.17385823
73. Bourhis J Blanchard P Maillard E Brizel DM Movsas B Buentzel J et al. Effect of amifostine on survival among patients treated with radiotherapy: a meta-analysis of individual patient data. J Clin Oncol (2011) 29(18):2590–7.10.1200/JCO.2010.33.145421576630
74. Nicolatou-Galitis O Sarri T Bowen J Di Palma M Kouloulias VE Niscola P et al. Systematic review of amifostine for the management of oral mucositis in cancer patients. Support Care Cancer (2013) 21(1):357–64.10.1007/s00520-012-1613-6
75. Duval M Daniel SJ. Meta-analysis of the efficacy of amifostine in the prevention of cisplatin ototoxicity. J Otolaryngol Head Neck Surg (2012) 41(5):309–15.23092832
76. Koukourakis MI Panteliadou M Abatzoglou IM Sismanidou K Sivridis E Giatromanolaki A. Postmastectomy hypofractionated and accelerated radiation therapy with (and without) subcutaneous amifostine cytoprotection. Int J Radiat Oncol Biol Phys (2013) 85(1):e7–13.10.1016/j.ijrobp.2012.08.01723040218
77. Praetorius NP Mandal TK. Alternate delivery route for amifostine as a radio-/chemo-protecting agent. J Pharm Pharmacol (2008) 60(7):809–15.10.1211/jpp.60.7.000118549666
78. Seed TM Inal CE Singh VK. Radioprotection of hematopoietic progenitors by low dose amifostine prophylaxis. Int J Radiat Biol (2014) 90(7):594–604.10.3109/09553002.2014.89945024597748
79. Finch PW Mark Cross LJ McAuley DF Farrell CL. Palifermin for the protection and regeneration of epithelial tissues following injury: new findings in basic research and pre-clinical models. J Cell Mol Med (2013) 17(9):1065–87.10.1111/jcmm.1209124151975
80. Vadhan-Raj S Goldberg JD Perales MA Berger DP van den Brink MR. Clinical applications of palifermin: amelioration of oral mucositis and other potential indications. J Cell Mol Med (2013) 17(11):1371–84.10.1111/jcmm.1216924251854
81. Lauritano D Petruzzi M Di Stasio D Lucchese A. Clinical effectiveness of palifermin in prevention and treatment of oral mucositis in children with acute lymphoblastic leukaemia: a case-control study. Int J Oral Sci (2014) 6(1):27–30.10.1038/ijos.2013.9324357856
82. Epperly MW Bray JA Krager S Berry LM Gooding W Engelhardt JF et al. Intratracheal injection of adenovirus containing the human MnSOD transgene protects athymic nude mice from irradiation-induced organizing alveolitis. Int J Radiat Oncol Biol Phys (1999) 43(1):169–81.10.1016/S0360-3016(98)00355-19989524
83. Epperly MW Defilippi S Sikora C Gretton J Kalend A Greenberger JS. Intratracheal injection of manganese superoxide dismutase (MnSOD) plasmid/liposomes protects normal lung but not orthotopic tumors from irradiation. Gene Ther (2000) 7(12):1011–8.10.1038/sj.gt.330120710871749
84. Epperly MW Gretton JA DeFilippi SJ Greenberger JS Sikora CA Liggitt D et al. Modulation of radiation-induced cytokine elevation associated with esophagitis and esophageal stricture by manganese superoxide dismutase-plasmid/liposome (SOD2-PL) gene therapy. Radiat Res (2001) 155(1 Pt 1):2–14.10.1667/0033-7587(2001)155[0002:MORICE]2.0.CO;211121210
85. Epperly MW Kagan VE Sikora CA Gretton JE Defilippi SJ Bar-Sagi D et al. Manganese superoxide dismutase-plasmid/liposome (MnSOD-PL) administration protects mice from esophagitis associated with fractionated radiation. Int J Cancer (2001) 96(4):221–31.10.1002/ijc.102311474496
86. Epperly MW Sikora CA DeFilippi SJ Gretton JA Zhan Q Kufe DW et al. Manganese superoxide dismutase (SOD2) inhibits radiation-induced apoptosis by stabilization of the mitochondrial membrane. Radiat Res (2002) 157(5):568–77.10.1667/0033-7587(2002)157[0568:MSDSIR]2.0.CO;211966323
87. Guo H Seixas-Silva JA Jr Epperly MW Gretton JE Shin DM Bar-Sagi D et al. Prevention of radiation-induced oral cavity mucositis by plasmid/liposome delivery of the human manganese superoxide dismutase (SOD2) transgene. Radiat Res (2003) 159(3):361–70.10.1667/0033-7587(2003)159[0361:PORIOC]2.0.CO;212600239
88. Epperly MW Gretton JE Sikora CA Jefferson M Bernarding M Nie S et al. Mitochondrial localization of superoxide dismutase is required for decreasing radiation-induced cellular damage. Radiat Res (2003) 160(5):568–78.10.1667/RR308114565825
89. Greenberger JS. Gene therapy approaches for stem cell protection. Gene Ther (2008) 15(2):100–8.10.1038/sj.gt.330300417700708
90. Epperly MW Chaillet JR Kalash R Shaffer B Goff J Franicola D et al. Conditional radioresistance of Tet-inducible manganese superoxide dismutase bone marrow stromal cell lines. Radiat Res (2013) 180(2):189–204.10.1667/RR3177.123862693
91. Epperly MW Wang H Jones JA Dixon T Montesinos CA Greenberger JS. Antioxidant-chemoprevention diet ameliorates late effects of total-body irradiation and supplements radioprotection by MnSOD-plasmid liposome administration. Radiat Res (2011) 175(6):759–65.10.1667/RR2398.121466381
92. Epperly MW Smith T Zhang X Goff JP Franicola D Greenberger B et al. Modulation of in utero total body irradiation induced newborn mouse growth retardation by maternal manganese superoxide dismutase-plasmid liposome (MnSOD-PL) gene therapy. Gene Ther (2011) 18(6):579–83.10.1038/gt.2010.17821248791
93. Epperly MW Franicola D Shields D Rwigema JC Stone B Zhang X et al. Screening of antimicrobial agents for in vitro radiation protection and mitigation capacity, including those used in supportive care regimens for bone marrow transplant recipients. In vivo (2010) 24(1):9–19.20133970
94. Mustata G Li M Zevola N Bakan A Zhang L Epperly M et al. Development of small-molecule PUMA inhibitors for mitigating radiation-induced cell death. Curr Top Med Chem (2011) 11(3):281–90.10.2174/15680261179407264121320058
95. Greenberger JS Clump D Kagan V Bayir H Lazo JS Wipf P et al. Strategies for discovery of small molecule radiation protectors and radiation mitigators. Front Oncol (2011) 1:59.10.3389/fonc.2011.0005922655254
96. Kim H Bernard ME Epperly MW Shen H Amoscato A Dixon TM et al. Amelioration of radiation esophagitis by orally administered p53/Mdm2/Mdm4 inhibitor (BEB55) or GS-nitroxide. In vivo (2011) 25(6):841–8.22021675
97. Kruk I Aboul-Enein HY Michalska T Lichszteld K Kladna A. Scavenging of reactive oxygen species by the plant phenols genistein and oleuropein. Luminescence (2005) 20(2):81–9.10.1002/bio.80815803505
98. Akiyama T Ishida J Nakagawa S Ogawara H Watanabe S Itoh N et al. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem (1987) 262(12):5592–5.3106339
99. Valachovicova T Slivova V Sliva D. Cellular and physiological effects of soy flavonoids. Mini Rev Med Chem (2004) 4(8):881–7.10.2174/138955704340338715544549
100. Wu HJ Chan WH. Genistein protects methylglyoxal-induced oxidative DNA damage and cell injury in human mononuclear cells. Toxicol In vitro (2007) 21(3):335–42.10.1016/j.tiv.2006.09.00217049802
101. Hong H Landauer MR Foriska MA Ledney GD. Antibacterial activity of the soy isoflavone genistein. J Basic Microbiol (2006) 46(4):329–35.10.1002/jobm.20051007316847837
102. Verdrengh M Jonsson IM Holmdahl R Tarkowski A. Genistein as an anti-inflammatory agent. Inflamm Res (2003) 52(8):341–6.10.1007/s00011-003-1182-814504672
103. Kang JL Lee HW Lee HS Pack IS Chong Y Castranova V et al. Genistein prevents nuclear factor-kappa B activation and acute lung injury induced by lipopolysaccharide. Am J Respir Crit Care Med (2001) 164(12):2206–12.10.1164/ajrccm.164.12.210401711751189
104. Lian F Li Y Bhuiyan M Sarkar FH. p53-independent apoptosis induced by genistein in lung cancer cells. Nutr Cancer (1999) 33(2):125–31.10.1207/S15327914NC33020210368806
105. Comalada M Ballester I Bailon E Sierra S Xaus J Galvez J et al. Inhibition of pro-inflammatory markers in primary bone marrow-derived mouse macrophages by naturally occurring flavonoids: analysis of the structure-activity relationship. Biochem Pharmacol (2006) 72(8):1010–21.10.1016/j.bcp.2006.07.01616934226
106. Tacyildiz N Ozyoruk D Yavuz G Unal E Dincaslan H Dogu F et al. Soy isoflavones ameliorate the adverse effects of chemotherapy in children. Nutr Cancer (2010) 62(7):1001–5.10.1080/01635581.2010.50984120924976
107. Ahmad IU Forman JD Sarkar FH Hillman GG Heath E Vaishampayan U et al. Soy isoflavones in conjunction with radiation therapy in patients with prostate cancer. Nutr Cancer (2010) 62(7):996–1000.10.1080/01635581.2010.50983920924975
108. Landauer MR Srinivasan V Seed TM. Genistein treatment protects mice from ionizing radiation injury. J Appl Toxicol (2003) 23(6):379–85.10.1002/jat.904
109. Davis TA Clarke TK Mog SR Landauer MR. Subcutaneous administration of genistein prior to lethal irradiation supports multilineage, hematopoietic progenitor cell recovery and survival. Int J Radiat Biol (2007) 83(3):141–51.10.1080/0955300060113264217378522
110. Davis TA Mungunsukh O Zins S Day RM Landauer MR. Genistein induces radioprotection by hematopoietic stem cell quiescence. Int J Radiat Biol (2008) 84(9):713–26.10.1080/0955300080231777818821385
111. Para AE Bezjak A Yeung IW Van Dyk J Hill RP. Effects of genistein following fractionated lung irradiation in mice. Radiother Oncol (2009) 92(3):500–10.10.1016/j.radonc.2009.04.00519433340
112. Day RM Davis TA Barshishat-Kupper M McCart EA Tipton AJ Landauer MR. Enhanced hematopoietic protection from radiation by the combination of genistein and captopril. Int Immunopharmacol (2013) 15(2):348–56.10.1016/j.intimp.2012.12.02923328620
113. Mahmood J Jelveh S Calveley V Zaidi A Doctrow SR Hill RP. Mitigation of radiation-induced lung injury by genistein and EUK-207. Int J Radiat Biol (2011) 87(8):889–901.10.3109/09553002.2011.58331521675818
114. Grace MB Blakely WF Landauer MR. Genistein-induced alterations of radiation-responsive gene expression. Radiat Meas (2007) 42:1152–7.10.1016/j.radmeas.2007.05.011
115. Oki T Sowa Y Hirose T Takagaki N Horinaka M Nakanishi R et al. Genistein induces Gadd45 gene and G2/M cell cycle arrest in the DU145 human prostate cancer cell line. FEBS Lett (2004) 577(1–2):55–9.10.1016/j.febslet.2004.09.08515527761
116. Caetano B Le Corre L Chalabi N Delort L Bignon YJ Bernard-Gallon DJ. Soya phytonutrients act on a panel of genes implicated with BRCA1 and BRCA2 oncosuppressors in human breast cell lines. Br J Nutr (2006) 95(2):406–13.10.1079/BJN2005164016469160
117. Tamulevicius P Wang M Iliakis G. Homology-directed repair is required for the development of radioresistance during S phase: interplay between double-strand break repair and checkpoint response. Radiat Res (2007) 167(1):1–11.10.1667/RR0751.117214519
118. Ha CT Li XH Fu D Xiao M Landauer MR. Genistein nanoparticles protect mouse hematopoietic system and prevent proinflammatory factors after gamma irradiation. Radiat Res (2013) 180(3):316–25.10.1667/RR3326.123952576
119. Kim H Peterson TG Barnes S. Mechanisms of action of the soy isoflavone genistein: emerging role for its effects via transforming growth factor β signaling pathways. Am J Clin Nutr (1998) 68S:1418S–25S.9848510
120. Robbins ME Diz DI. Pathogenic role of the renin-angiotensin system in modulating radiation-induced late effects. Int J Radiat Oncol Biol Phys (2006) 64(1):6–12.10.1016/j.ijrobp.2005.08.033
121. Robbins ME Hopewell JW. Physiological factors effecting renal radiation tolerance: a guide to the treatment of late effects. Br J Cancer Suppl (1986) 7:265–7.
122. Davis TA Landauer MR Mog SR Barshishat-Kupper M Zins SR Amare MF et al. Timing of captopril administration determines radiation protection or radiation sensitization in a murine model of total body irradiation. Exp Hematol (2010) 38(4):270–81.10.1016/j.exphem.2010.01.00420116413
123. Moulder JE Cohen EP Fish BL. Captopril and losartan for mitigation of renal injury caused by single-dose total-body irradiation. Radiat Res (2011) 175(1):29–36.10.1667/RR2400.121175344
124. Kma L Gao F Fish BL Moulder JE Jacobs ER Medhora M. Angiotensin converting enzyme inhibitors mitigate collagen synthesis induced by a single dose of radiation to the whole thorax. J Radiat Res (2012) 53(1):10–7.10.1269/jrr.1103522302041
125. Medhora M Gao F Jacobs ER Moulder JE. Radiation damage to the lung: mitigation by angiotensin-converting enzyme (ACE) inhibitors. Respirology (2012) 17(1):66–71.10.1111/j.1440-1843.2011.02092.x22023053
126. Ghosh SN Zhang R Fish BL Semenenko VA Li XA Moulder JE et al. Renin-angiotensin system suppression mitigates experimental radiation pneumonitis. Int J Radiat Oncol Biol Phys (2009) 75(5):1528–36.10.1016/j.ijrobp.2009.07.174319931735
127. Moulder JE Cohen EP. Future strategies for mitigation and treatment of chronic radiation-induced normal tissue injury. Semin Radiat Oncol (2007) 17(2):141–8.10.1016/j.semradonc.2006.11.01017395044
128. Ward WF Kim YT Molteni A Solliday NH. Radiation-induced pulmonary endothelial dysfunction in rats: modification by an inhibitor of angiotensin converting enzyme. Int J Radiat Oncol Biol Phys (1988) 15(1):135–40.10.1016/0360-3016(88)90357-43292488
129. Ward WF Molteni A Ts’ao C Hinz JM. The effect of captopril on benign and malignant reactions in irradiated rat skin. Br J Radiol (1990) 63(749):349–54.10.1259/0007-1285-63-749-3492198982
130. Cohen EP Fish BL Moulder JE. Treatment of radiation nephropathy with captopril. Radiat Res (1992) 132(3):346–50.10.2307/35782431475357
131. Moulder JE Cohen EP Fish BL Hill P. Prophylaxis of bone marrow transplant nephropathy with captopril, an inhibitor of angiotensin-converting enzyme. Radiat Res (1993) 136(3):404–7.10.2307/35785548278583
132. Cohen EP Irving AA Drobyski WR Klein JP Passweg J Talano JA et al. Captopril to mitigate chronic renal failure after hematopoietic stem cell transplantation: a randomized controlled trial. Int J Radiat Oncol Biol Phys (2008) 70(5):1546–51.10.1016/j.ijrobp.2007.08.04118029109
133. Charrier S Michaud A Badaoui S Giroux S Ezan E Sainteny F et al. Inhibition of angiotensin I-converting enzyme induces radioprotection by preserving murine hematopoietic short-term reconstituting cells. Blood (2004) 104(4):978–85.10.1182/blood-2003-11-382815105290
134. Zakheim RM Mattioli L Molteni A Mullis KB Bartley J. Prevention of pulmonary vascular changes of chronic alveolar hypoxia by inhibition of angiotensin I-converting enzyme in the rat. Lab Invest (1975) 33(1):57–61.167232
135. Chisi JE Briscoe CV Ezan E Genet R Riches AC Wdzieczak-Bakala J. Captopril inhibits in vitro and in vivo the proliferation of primitive haematopoietic cells induced into cell cycle by cytotoxic drug administration or irradiation but has no effect on myeloid leukaemia cell proliferation. Br J Haematol (2000) 109(3):563–70.10.1046/j.1365-2141.2000.02073.x10886205
136. Aggarwal BB Ichikawa H. Molecular targets and anticancer potential of indole-3-carbinol and its derivatives. Cell Cycle (2005) 4(9):1201–15.10.4161/cc.4.9.199316082211
137. Reed GA Arneson DW Putnam WC Smith HJ Gray JC Sullivan DK et al. Single-dose and multiple-dose administration of indole-3-carbinol to women: pharmacokinetics based on 3,3’-diindolylmethane. Cancer Epidemiol Biomarkers Prev (2006) 15(12):2477–81.10.1158/1055-9965.EPI-06-039617164373
138. Reed GA Sunega JM Sullivan DK Gray JC Mayo MS Crowell JA et al. Single-dose pharmacokinetics and tolerability of absorption-enhanced 3,3’-diindolylmethane in healthy subjects. Cancer Epidemiol Biomarkers Prev (2008) 17(10):2619–24.10.1158/1055-9965.EPI-08-052018843002
139. Heath EI Heilbrun LK Li J Vaishampayan U Harper F Pemberton P et al. A phase I dose-escalation study of oral BR-DIM (BioResponse 3,3’-diindolylmethane) in castrate-resistant, non-metastatic prostate cancer. Am J Transl Res (2010) 2(4):402–11.20733950
140. Del Priore G Gudipudi DK Montemarano N Restivo AM Malanowska-Stega J Arslan AA. Oral diindolylmethane (DIM): pilot evaluation of a nonsurgical treatment for cervical dysplasia. Gynecol Oncol (2010) 116(3):464–7.10.1016/j.ygyno.2009.10.06019939441
141. Fan S Meng Q Xu J Jiao Y Zhao L Zhang X et al. DIM (3,3’-diindolylmethane) confers protection against ionizing radiation by a unique mechanism. Proc Natl Acad Sci U S A (2013) 110(46):18650–5.10.1073/pnas.130820611024127581
142. Yao Z Hu W Yin S Huang Z Zhu Q Chen J et al. 3,3’-Diindolymethane ameliorates adriamycin-induced cardiac fibrosis via activation of a BRCA1-dependent anti-oxidant pathway. Pharmacol Res (2013) 70(1):139–46.10.1016/j.phrs.2013.01.00623376355
143. Zong J Deng W Zhou H Bian ZY Dai J Yuan Y et al. 3,3’-Diindolylmethane protects against cardiac hypertrophy via 5’-adenosine monophosphate-activated protein kinase-alpha2. PLoS One (2013) 8(1):e53427.10.1371/journal.pone.005342723326427
144. Panganiban RA Mungunsukh O Day RM. X-irradiation induces ER stress, apoptosis, and senescence in pulmonary artery endothelial cells. Int J Radiat Biol (2012) 89(8):656–67.10.3109/09553002.2012.71150222788682
145. Iglesias-Bartolome R Patel V Cotrim A Leelahavanichkul K Molinolo AA Mitchell JB et al. mTOR inhibition prevents epithelial stem cell senescence and protects from radiation-induced mucositis. Cell Stem Cell (2012) 11(3):401–14.10.1016/j.stem.2012.06.00722958932
146. Igarashi K Sakimoto I Kataoka K Ohta K Miura M. Radiation-induced senescence-like phenotype in proliferating and plateau-phase vascular endothelial cells. Exp Cell Res (2007) 313(15):3326–36.10.1016/j.yexcr.2007.06.00117662979
147. Oh CW Bump EA Kim JS Janigro D Mayberg MR. Induction of a senescence-like phenotype in bovine aortic endothelial cells by ionizing radiation. Radiat Res (2001) 156(3):232–40.10.1667/0033-7587(2001)156[0232:IOASLP]2.0.CO;211500132
148. Muller M. Cellular senescence: molecular mechanisms, in vivo significance, and redox considerations. Antioxid Redox Signal (2009) 11(1):59–98.10.1089/ars.2008.210418976161
149. Chen J Goligorsky MS. Premature senescence of endothelial cells: Methusaleh’s dilemma. Am J Physiol Heart Circ Physiol (2006) 290(5):H1729–39.10.1152/ajpheart.01103.200516603702
150. Cmielova J Havelek R Soukup T Jiroutova A Visek B Suchanek J et al. Gamma radiation induces senescence in human adult mesenchymal stem cells from bone marrow and periodontal ligaments. Int J Radiat Biol (2012) 88(5):393–404.10.3109/09553002.2012.66600122348537
151. Lewis DA Yi Q Travers JB Spandau DF. UVB-induced senescence in human keratinocytes requires a functional insulin-like growth factor-1 receptor and p53. Mol Biol Cell (2008) 19(4):1346–53.10.1091/mbc.E07-10-104118216278
152. Holzenberger M Dupont J Ducos B Leneuve P Geloen A Even PC et al. IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature (2003) 421(6919):182–7.10.1038/nature0129812483226
153. Handayaningsih AE Takahashi M Fukuoka H Iguchi G Nishizawa H Yamamoto M et al. IGF-I enhances cellular senescence via the reactive oxygen species-p53 pathway. Biochem Biophys Res Commun (2012) 425(2):478–84.10.1016/j.bbrc.2012.07.14022877754
154. Tran D. IGF-1 Induces Premature Cellular Senescence Through Inhibition of Sirt1 and Activation Ofp53 [Dissertation]. Boston, MA: Division of Graduate Medical Sciences, Boston University (2008).
155. Costantini C Lorenzetto E Cellini B Buffelli M Rossi F Della-Bianca V. Astrocytes regulate the expression of insulin-like growth factor 1 receptor (IGF1-R) in primary cortical neurons during in vitro senescence. J Mol Neurosci (2010) 40(3):342–52.10.1007/s12031-009-9305-519862643
156. Panganiban RA Day RM. Inhibition of IGF-1R prevents ionizing radiation-induced primary endothelial cell senescence. PLoS One (2013) 8:e78589.10.1371/journal.pone.007858924205274
157. Vijay-Kumar M Aitken JD Sanders CJ Frias A Sloane VM Xu J et al. Flagellin treatment protects against chemicals, bacteria, viruses, and radiation. J Immunol (2008) 180(12):8280–5.10.4049/jimmunol.180.12.828018523294
158. Burdelya LG Krivokrysenko VI Tallant TC Strom E Gleiberman AS Gupta D et al. An agonist of toll-like receptor 5 has radioprotective activity in mouse and primate models. Science (2008) 320(5873):226–30.10.1126/science.115498618403709
159. Krivokrysenko VI Shakhov AN Singh VK Bone F Kononov Y Shyshynova I et al. Identification of granulocyte colony-stimulating factor and interleukin-6 as candidate biomarkers of CBLB502 efficacy as a medical radiation countermeasure. J Pharmacol Exp Ther (2012) 343(2):497–508.10.1124/jpet.112.19607122837010
160. Burdelya LG Gleiberman AS Toshkov I Aygun-Sunar S Bapardekar M Manderscheid-Kern P et al. Toll-like receptor 5 agonist protects mice from dermatitis and oral mucositis caused by local radiation: implications for head-and-neck cancer radiotherapy. Int J Radiat Oncol Biol Phys (2012) 83(1):228–34.10.1016/j.ijrobp.2011.05.05522000579
161. Ghosh SP Perkins MW Hieber K Kulkarni S Kao TC Reddy EP et al. Radiation protection by a new chemical entity, Ex-Rad: efficacy and mechanisms. Radiat Res (2009) 171(2):173–9.10.1667/RR1367.119267542
162. Suman S Datta K Doiron K Ren C Kumar R Taft DR et al. Radioprotective effects of ON 01210.Na upon oral administration. J Radiat Res (2012) 53(3):368–76.22739006
163. Ghosh SP Kulkarni S Perkins MW Hieber K Pessu RL Gambles K et al. Amelioration of radiation-induced hematopoietic and gastrointestinal damage by Ex-RAD(R) in mice. J Radiat Res (2012) 53(4):526–36.10.1093/jrr/rrs00122843617
164. Suman S Maniar M Fornace AJ Jr Datta K. Administration of ON 01210.Na after exposure to ionizing radiation protects bone marrow cells by attenuating DNA damage response. Radiat Oncol (2012) 7:6.10.1186/1748-717X-7-622264334
165. Kang AD Cosenza SC Bonagura M Manair M Reddy MV Reddy EP. ON01210.Na (Ex-RAD(R)) mitigates radiation damage through activation of the AKT pathway. PLoS One (2013) 8(3):e58355.10.1371/journal.pone.005835523505494
166. Singh VK Newman VL Romaine PL Wise SY Seed TM. Radiation countermeasure agents: an update (2011-2014). Expert Opin Ther Pat (2014) 24(11):1229–55.10.1517/13543776.2014.96468425315070
167. Ghosh SP Kulkarni S Hieber K Toles R Romanyukha L Kao TC et al. Gamma-tocotrienol, a tocol antioxidant as a potent radioprotector. Int J Radiat Biol (2009) 85(7):598–606.10.1080/0955300090298512819557601
168. Kulkarni S Ghosh SP Satyamitra M Mog S Hieber K Romanyukha L et al. Gamma-tocotrienol protects hematopoietic stem and progenitor cells in mice after total-body irradiation. Radiat Res (2010) 173(6):738–47.10.1667/RR1824.120518653
169. Suman S Datta K Chakraborty K Kulkarni SS Doiron K Fornace AJ Jr et al. Gamma tocotrienol, a potent radioprotector, preferentially upregulates expression of anti-apoptotic genes to promote intestinal cell survival. Food Chem Toxicol (2013) 60:488–96.10.1016/j.fct.2013.08.01123941772
170. Kulkarni S Singh PK Ghosh SP Posarac A Singh VK. Granulocyte colony-stimulating factor antibody abrogates radioprotective efficacy of gamma-tocotrienol, a promising radiation countermeasure. Cytokine (2013) 62(2):278–85.10.1016/j.cyto.2013.03.00923561424
171. Satyamitra M Kulkarni S Ghosh SP Mullaney C Condliffe D Srinivasan V. Hematopoietic recovey and amelioration of radiation-induced lethality by the vitamin E isoform, delta-tocotrienol. Radiat Res (2011) 175:736–45.10.1667/RR2460.121434782
172. Li XH Fu D Latif NH Mullaney CP Ney PH Mog SR et al. Delta-tocotrienol protects mouse and human hematopoietic progenitors from gamma-irradiation through extracellular signal-regulated kinase/mammalian target of rapamycin signaling. Haematologica (2010) 95(12):1996–2004.10.3324/haematol.2010.02649220823133
173. Singh VK Wise SY Scott JR Romaine LP Newman VL Fatanmi OO. Radioprotective efficacy of delta-tocotrienol, a vitamin E isoform, is mediated through granulocyte colony-stimulating factor. Life Sci (2014) 98:113–22.10.1016/j.lfs.2014.01.06524486300
174. Singh VK Romaine PL Newman VL Seed TM. Tocols induce G-CSF and mobilise progenitors that mitigate radiation injury. Radiat Prot Dosimetry (2014) 162(1–2):83–7.10.1093/rpd/ncu22324993008
175. Satyamitra M Ney P Graves J III Mullaney C Srinivasan V. Mechanism of radioprotection by delta-tocotrienol: pharmacokinetics, pharmacodynamics and modulation of signalling pathways. Br J Radiol (2012) 85(1019):e1093–103.10.1259/bjr/6335584422674714
176. Bhanja P Saha S Kabarriti R Liu L Roy-Chowdhury N Roy-Chowdhury J et al. Protective role of R-spondin1, an intestinal stem cell growth factor, against radiation-induced gastrointestinal syndrome in mice. PLoS One (2009) 4(11):e8014.10.1371/journal.pone.000801419956666
177. Xu L Xiong S Guo R Yang Z Wang Q Xiao F et al. Transforming growth factor beta3 attenuates the development of radiation-induced pulmonary fibrosis in mice by decreasing fibrocyte recruitment and regulating IFN-gamma/IL-4 balance. Immunol Lett (2014) 162(1 Pt A):27–33.10.1016/j.imlet.2014.06.01024996042
178. Prockop DJ. Further proof for an unpopular concept: a single cell from bone marrow can serve as a stem cell for both hematopoiesis and osteogenesis. Mol Ther (2013) 21(6):1116–7.10.1038/mt.2013.103
179. Prockop DJ Gregory CA Spees JL. One strategy for cell and gene therapy: harnessing the power of adult stem cells to repair tissues. Proc Natl Acad Sci U S A (2003) 100(Suppl 1):11917–23.10.1073/pnas.183413810013679583
180. Semont A Francois S Mouiseddine M Francois A Sache A Frick J et al. Mesenchymal stem cells increase self-renewal of small intestinal epithelium and accelerate structural recovery after radiation injury. Adv Exp Med Biol (2006) 585:19–30.10.1007/978-0-387-34133-0_217120774
181. Prockop DJ Brenner M Fibbe WE Horwitz E Le Blanc K Phinney DG et al. Defining the risks of mesenchymal stromal cell therapy. Cytotherapy (2010) 12(5):576–8.10.3109/14653249.2010.50733020735162
182. Nadir Y Brenner B. Thrombotic complications associated with stem cell transplantation. Blood Rev (2012) 26(5):183–7.10.1016/j.blre.2012.05.001
183. Abdel-Mageed AS Senagore AJ Pietryga DW Connors RH Giambernardi TA Hay RV et al. Intravenous administration of mesenchymal stem cells genetically modified with extracellular superoxide dismutase improves survival in irradiated mice. Blood (2009) 113(5):1201–3.10.1182/blood-2008-07-170936
184. Saha S Bhanja P Kabarriti R Liu L Alfieri AA Guha C. Bone marrow stromal cell transplantation mitigates radiation-induced gastrointestinal syndrome in mice. PLoS One (2011) 6(9):e24072.10.1371/journal.pone.002407221935373
185. Singh VK Christensen J Fatanmi OO Gille D Ducey EJ Wise SY et al. Myeloid progenitors: a radiation countermeasure that is effective when initiated days after irradiation. Radiat Res (2012) 177:781–91.10.1667/RR2894.122559205
186. Singh VK Brown DS Kao TC. Alpha-tocopherol succinate protects mice from gamma-radiation by induction of granulocyte-colony stimulating factor. Int J Radiat Biol (2010) 86(1):12–21.10.3109/0955300090326451520070211
187. Singh VK Brown DS Kao TC Seed TM. Preclinical development of a bridging therapy for radiation casualties. Exp Hematol (2010) 38(1):61–70.10.1016/j.exphem.2009.10.00819853015
188. Singh VK Wise SY Singh PK Ducey EJ Fatanmi OO Seed TM. Alpha-tocopherol succinate- and AMD3100-mobilized progenitors mitigate radiation-induced gastrointestinal injury in mice. Exp Hematol (2012) 40(5):407–17.10.1016/j.exphem.2012.01.00522240608
189. Singh VK Wise SY Singh PK Posarac A Fatanmi OO Ducey EJ et al. Alpha-tocopherol succinate-mobilized progenitors improve intestinal integrity after whole body irradiation. Int J Radiat Biol (2013) 89(5):334–45.10.3109/09553002.2013.76213723270472
190. Singh VK Wise SY Fatanmi OO Beattie LA Ducey EJ Seed TM. Alpha-tocopherol succinate- and AMD3100-mobilized progenitors mitigate radiation combined injury in mice. J Radiat Res (2014) 55(1):41–53.10.1093/jrr/rrt08823814114
191. Singh VK Ducey EJ Fatanmi OO Singh PK Brown DS Purmal A et al. CBLB613: a TLR 2/6 agonist, natural lipopeptide of Mycoplasma arginini, as a novel radiation countermeasure. Radiat Res (2012) 177(5):628–42.10.1667/RR2657.122175300
192. Shakhov AN Singh VK Bone F Cheney A Kononov Y Krasnov P et al. Prevention and mitigation of acute radiation syndrome in mice by synthetic lipopeptide agonists of toll-like receptor 2 (TLR2). PLoS One (2012) 7(3):e33044.10.1371/journal.pone.003304422479357
193. Gluzman-Poltorak Z Mendonca SR Vainstein V Kha H Basile LA. Randomized comparison of single dose of recombinant human IL-12 versus placebo for restoration of hematopoiesis and improved survival in rhesus monkeys exposed to lethal radiation. J Hematol Oncol (2014) 7:31.10.1186/1756-8722-7-3124708888
194. Doan PL Himburg HA Helms K Russell JL Fixsen E Quarmyne M et al. Epidermal growth factor regulates hematopoietic regeneration after radiation injury. Nat Med (2013) 19(3):295–304.10.1038/nm.307023377280
195. Zhang L Sun W Wang J Zhang M Yang S Tian Y et al. Mitigation effect of an FGF-2 peptide on acute gastrointestinal syndrome after high-dose ionizing radiation. Int J Radiat Oncol Biol Phys (2010) 77(1):261–8.10.1016/j.ijrobp.2009.11.02620394858
196. Ma J Hou Y Han D Zhang M Chen C Zhang B et al. Fibroblast growth factor-peptide promotes bone marrow recovery after irradiation. Adv Exp Med Biol (2013) 765:155–61.10.1007/978-1-4614-4989-8_2222879028
197. Zhou D Deoliveira D Kang Y Choi SS Li Z Chao NJ et al. Insulin-like growth factor 1 mitigates hematopoietic toxicity after lethal total body irradiation. Int J Radiat Oncol Biol Phys (2013) 85(4):1141–8.10.1016/j.ijrobp.2012.08.01423021438
198. Mitchell JB Anver MR Sowers AL Rosenberg PS Figueroa M Thetford A et al. The antioxidant tempol reduces carcinogenesis and enhances survival in mice when administered after nonlethal total body radiation. Cancer Res (2012) 72(18):4846–55.10.1158/0008-5472.CAN-12-187922805306
199. Satyamitra M Lombardini E Graves IIIJ Mullaney C Ney P Hunter A et al. A TPO receptor agonist, ALXN4100TPO, mitigates radiation-induced lethality and stimulates hematopoiesis in CD2F1 mice. Radiat Res (2011) 175(6):746–58.10.1667/RR2462.121476857
200. Singh VK Ducey EJ Brown DS Whitnall MH. A review of radiation countermeasure work ongoing at the Armed Forces Radiobiology Research Institute. Int J Radiat Biol (2012) 88(4):296–310.10.3109/09553002.2012.65272622191567
201. Garofalo MC Ward AA Farese AM Bennett A Taylor-Howell C Cui W et al. A pilot study in rhesus macaques to assess the treatment efficacy of a small molecular weight catalytic metalloporphyrin antioxidant (AEOL 10150) in mitigating radiation-induced lung damage. Health Phys (2014) 106(1):73–83.10.1097/HP.0b013e3182a4d967
202. Singh VK Newman VL Seed TM. Colony-stimulating factors for the treatment of the hematopoietic component of the acute radiation syndrome (H-ARS): a review. Cytokine (2015) 71(1):22–37.10.1016/j.cyto.2014.08.00325215458